RCKT Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Clinical Progress ESLA Q1 2026 Earnings EPS Misses Estimates by Wide Margin as ClinicalStage Biotech Continues RD Spending URG Q1 2026 Earnings Wide EPS Miss as Development Continues Stock Edges Higher GPCR Q1 2026 Earnings Narrower Loss Highlights ClinicalStage Progress TRV Q1 2026 Earnings Strong EPS Beat of 785 Masks Slight Stock Decline EQX Q1 2026 Earnings EPS Falls Just Short of Estimates as Gold Production Remains Steady